These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11028832)

  • 61. Safety, tolerability, efficacy and plasma concentrations of tropisetron after administration at five dose levels to children receiving cancer chemotherapy.
    Suarez A; Stettler ER; Rey E; Pons G; Simonetta-Chateauneuf C; de Bruijn KM; Olive G; Lemerle J
    Eur J Cancer; 1994; 30A(10):1436-41. PubMed ID: 7833098
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Tropisetron hydrochloride in preventing and treating chemotherapy-induced nausea and vomiting: a phase II, randomized, multicenter, double-blinded, comparative clinical trial].
    Zhang WD; Wang XW; Chen ZD; Qin FZ; Shu YQ; Pan LX; Zhang MH
    Ai Zheng; 2007 Aug; 26(8):870-3. PubMed ID: 17697550
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effects of 5-HT(3) receptor antagonists on daily alcohol intake under acquisition, maintenance, and relapse conditions in alcohol-preferring (P) rats.
    Rodd-Henricks ZA; McKinzie DL; Edmundson VE; Dagon CL; Murphy JM; McBride WJ; Lumeng L; Li TK
    Alcohol; 2000 May; 21(1):73-85. PubMed ID: 10946160
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effect of tropisetron on vomiting during patient-controlled analgesia in children.
    Allen D; Jorgensen C; Sims C
    Br J Anaesth; 1999 Oct; 83(4):608-10. PubMed ID: 10673878
    [TBL] [Abstract][Full Text] [Related]  

  • 65. 5-HT3 receptor antagonists for the prevention of chemotherapy-induced nausea and vomiting. A comparison of their pharmacology and clinical efficacy.
    Gregory RE; Ettinger DS
    Drugs; 1998 Feb; 55(2):173-89. PubMed ID: 9506240
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A randomized, placebo-controlled trial of a single dose of tropisetron for the prevention of vomiting after strabismus surgery in children.
    Tosun Z; Akin A; Dogan H; Boyaci A
    Mt Sinai J Med; 2006 Dec; 73(8):1106-11. PubMed ID: 17285204
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Double-blind, multicenter trial comparing acetyl l-carnitine with placebo in the treatment of fibromyalgia patients.
    Rossini M; Di Munno O; Valentini G; Bianchi G; Biasi G; Cacace E; Malesci D; La Montagna G; Viapiana O; Adami S
    Clin Exp Rheumatol; 2007; 25(2):182-8. PubMed ID: 17543140
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Analgesic effect of acetaminophen in humans: first evidence of a central serotonergic mechanism.
    Pickering G; Loriot MA; Libert F; Eschalier A; Beaune P; Dubray C
    Clin Pharmacol Ther; 2006 Apr; 79(4):371-8. PubMed ID: 16580905
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effects on muscle pain by intramuscular injection of granisetron in patients with fibromyalgia.
    Ernberg M; Lundeberg T; Kopp S
    Pain; 2003 Feb; 101(3):275-282. PubMed ID: 12583870
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Single dose i.v. tropisetron in the prevention of postoperative nausea and vomiting after gynaecological surgery.
    Capouet V; De Pauw C; Vernet B; Ivens D; Derijcke V; Versichelen L; van Aken H; Ickx B; Ritter L; Hulstaert F
    Br J Anaesth; 1996 Jan; 76(1):54-60. PubMed ID: 8672381
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels.
    Younger J; Noor N; McCue R; Mackey S
    Arthritis Rheum; 2013 Feb; 65(2):529-38. PubMed ID: 23359310
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The antipruritic effect of a 5-HT3 receptor antagonist (tropisetron) is dependent on mast cell depletion--an experimental study.
    Weisshaar E; Ziethen B; Röhl FW; Gollnick H
    Exp Dermatol; 1999 Aug; 8(4):254-60. PubMed ID: 10439222
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Analgesic effects of 5-HT3 receptor antagonists.
    Riering K; Rewerts C; Zieglgänsberger W
    Scand J Rheumatol Suppl; 2004; 119():19-23. PubMed ID: 15515407
    [TBL] [Abstract][Full Text] [Related]  

  • 74. 5-HT3 receptor antagonist, tropisetron, does not influence ethanol-induced conditioned taste aversion and conditioned place aversion.
    Bienkowski P; Kuca P; Piasecki J; Kostowski W
    Alcohol; 1997; 14(1):63-9. PubMed ID: 9014026
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effects of metoclopramide and tropisetron on aldosterone secretion possibly due to agonism and antagonism at the 5-HT4 receptor.
    Sommers DK; Snyman JR; van Wyk M
    Eur J Clin Pharmacol; 1996; 50(5):371-3. PubMed ID: 8839658
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The development of a protocol for the use of 5-HT3 antagonists in chemotherapy-induced nausea and vomiting.
    Watters J; Riley M; Pedley I; Whitehead A; Overend M; Goss I; Allgar V
    Clin Oncol (R Coll Radiol); 2001; 13(6):422-6. PubMed ID: 11824878
    [TBL] [Abstract][Full Text] [Related]  

  • 77. 5-HT3 receptor antagonists vs traditional agents for the prophylaxis of postoperative nausea and vomiting.
    Loewen PS; Marra CA; Zed PJ
    Can J Anaesth; 2000 Oct; 47(10):1008-18. PubMed ID: 11032279
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Pathogenetic aspects of responsiveness to ondansetron (5-hydroxytryptamine type 3 receptor antagonist) in patients with primary fibromyalgia syndrome--a preliminary study.
    Hrycaj P; Stratz T; Mennet P; Müller W
    J Rheumatol; 1996 Aug; 23(8):1418-23. PubMed ID: 8856622
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Safety and efficacy of esreboxetine in patients with fibromyalgia: a fourteen-week, randomized, double-blind, placebo-controlled, multicenter clinical trial.
    Arnold LM; Hirsch I; Sanders P; Ellis A; Hughes B
    Arthritis Rheum; 2012 Jul; 64(7):2387-97. PubMed ID: 22275142
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prospective randomized comparison of tropisetron with and without dexamethasone against high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting.
    Malik I; Moid I; Khan Z; Hussain M
    Am J Clin Oncol; 1999 Apr; 22(2):126-30. PubMed ID: 10199444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.